ATAI
Price
$2.48
Change
+$0.15 (+6.44%)
Updated
Jun 20 closing price
Capitalization
523.7M
58 days until earnings call
RAPP
Price
$10.92
Change
-$0.11 (-1.00%)
Updated
Jun 20 closing price
Capitalization
398.55M
47 days until earnings call
Interact to see
Advertisement

ATAI vs RAPP

Header iconATAI vs RAPP Comparison
Open Charts ATAI vs RAPPBanner chart's image
ATAI Life Sciences
Price$2.48
Change+$0.15 (+6.44%)
Volume$3.94M
Capitalization523.7M
Rapport Therapeutics
Price$10.92
Change-$0.11 (-1.00%)
Volume$104.16K
Capitalization398.55M
ATAI vs RAPP Comparison Chart in %
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. RAPP commentary
Jun 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and RAPP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 22, 2025
Stock price -- (ATAI: $2.48 vs. RAPP: $10.92)
Brand notoriety: ATAI and RAPP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 182% vs. RAPP: 61%
Market capitalization -- ATAI: $523.7M vs. RAPP: $398.55M
ATAI [@Biotechnology] is valued at $523.7M. RAPP’s [@Biotechnology] market capitalization is $398.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $333.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileRAPP’s FA Score has 1 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • RAPP’s FA Score: 1 green, 4 red.
According to our system of comparison, ATAI is a better buy in the long-term than RAPP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 6 TA indicator(s) are bullish while RAPP’s TA Score has 5 bullish TA indicator(s).

  • ATAI’s TA Score: 6 bullish, 4 bearish.
  • RAPP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than RAPP.

Price Growth

ATAI (@Biotechnology) experienced а +17.54% price change this week, while RAPP (@Biotechnology) price change was -2.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.57%. For the same industry, the average monthly price growth was +27.78%, and the average quarterly price growth was +14.34%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 18, 2025.

RAPP is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+9.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI($524M) has a higher market cap than RAPP($399M). ATAI YTD gains are higher at: 86.466 vs. RAPP (-38.444). RAPP has higher annual earnings (EBITDA): -92.14M vs. ATAI (-145.09M). RAPP has more cash in the bank: 285M vs. ATAI (98.2M). RAPP has less debt than ATAI: RAPP (7.84M) vs ATAI (26.7M). ATAI has higher revenues than RAPP: ATAI (1.86M) vs RAPP (0).
ATAIRAPPATAI / RAPP
Capitalization524M399M131%
EBITDA-145.09M-92.14M157%
Gain YTD86.466-38.444-225%
P/E RatioN/AN/A-
Revenue1.86M0-
Total Cash98.2M285M34%
Total Debt26.7M7.84M340%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
12

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAIRAPP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 6 days ago
88%
Declines
ODDS (%)
Bearish Trend 9 days ago
85%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEPSX13.82-0.01
-0.07%
JPMorgan Equity Premium Income R5
NSFFX11.62-0.02
-0.17%
Natixis Target Retirement 2030 N
VNSCX19.23-0.05
-0.26%
Natixis Vaughan Nelson Select C
CVGCX14.05-0.07
-0.50%
Calamos Growth C
JSPJX20.45-0.14
-0.68%
Jackson Square Large-Cap Growth Inv

RAPP and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPP has been loosely correlated with CELC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPP jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPP
1D Price
Change %
RAPP100%
-1.00%
CELC - RAPP
42%
Loosely correlated
-1.78%
ABSI - RAPP
39%
Loosely correlated
+1.45%
NUVB - RAPP
38%
Loosely correlated
N/A
MNMD - RAPP
38%
Loosely correlated
-0.56%
ATAI - RAPP
37%
Loosely correlated
+6.44%
More